No Data
Are Medical Stocks Lagging DURECT (DRRX) This Year?
H.C. Wainwright Maintains Durect(DRRX.US) With Hold Rating
H.C. Wainwright analyst Ed Arce maintains $Durect(DRRX.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 39.3% and a total average return of 8.6% over the past year
Northland Securities Maintains Durect(DRRX.US) With Buy Rating, Maintains Target Price $8.5
Northland Securities analyst Carl Byrnes maintains $Durect(DRRX.US)$ with a buy rating, and maintains the target price at $8.5.According to TipRanks data, the analyst has a success rate of 37.0% and a
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Durect (DRRX)
12 Health Care Stocks Moving In Tuesday's After-Market Session
Hearing Oppenheimer Reiterates Outperform And $5 PT On DURECT